Literature DB >> 2331409

Fibrin deposition and adaptive changes in glomerular procoagulant and fibrinolytic activities in rat renoprival nephropathy.

P Ruedin1, B Mougenot, D Ruedin, E Rondeau, J D Sraer, R Lacave, A Kanfer.   

Abstract

To investigate the mechanisms which may influence fibrin deposition in the remnant kidney, glomerular morphology and the haemostatic properties of isolated glomeruli were assessed in two groups of rats, 30 days after surgical removal of three-quarters of the total renal parenchyma, and compared to glomeruli in sham-operated controls. One group was given the thromboxane synthetase inhibitor OKY 046 and the other was not. Fibrin deposition occurred in about 20% of glomeruli, of which 4% exhibited segmental necrotizing lesions. Concomitantly, glomerular procoagulant activity dropped to 40% of the control level and glomerular fibrinolytic activity rose to 120-130% of this level. Inhibition of thromboxane synthesis did not affect fibrin deposition, glomerular haemostasis or the development of renal insufficiency. In an additional group of unilaterally nephrectomized rats, procoagulant activity also markedly decreased in the remaining kidney. These results indicate that in the rat remnant kidney, alterations in glomerular haemostatic properties tend to have antithrombotic effects which seem to constitute an adaptive reaction by an autacoid system to glomerular fibrin deposition.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2331409      PMCID: PMC1998707     

Source DB:  PubMed          Journal:  J Exp Pathol (Oxford)        ISSN: 0958-4625


  15 in total

1.  A rapid and sensitive 125I-fibrin solid-phase fibrinolytic assay for plasmin.

Authors:  L A Moroz; N J Gilmore
Journal:  Blood       Date:  1975-10       Impact factor: 22.113

2.  Quantitative assessment of procoagulant activity in isolated rat glomeruli.

Authors:  D de Prost; A Kanfer
Journal:  Kidney Int       Date:  1985-09       Impact factor: 10.612

3.  Mononuclear cell modulation of fibroblast procoagulant activity.

Authors:  J H Korn; F R Rickles; V A Ewan; R L Edwards; T J Myers; O Onder
Journal:  J Lab Clin Med       Date:  1982-05

4.  Role of heparin as a protective agent following reduction of renal mass.

Authors:  J L Olson
Journal:  Kidney Int       Date:  1984-02       Impact factor: 10.612

5.  Inhibition of thromboxane synthesis ameliorates the progressive kidney disease of rats with subtotal renal ablation.

Authors:  M L Purkerson; J H Joist; J Yates; A Valdes; A Morrison; S Klahr
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

6.  Effects of fibrinogen degradation products on glomerular mesangial cells in culture.

Authors:  T Tsumagari; K Tanaka
Journal:  Kidney Int       Date:  1984-11       Impact factor: 10.612

7.  Prostaglandin and thromboxane formation in glomeruli from rats with reduced renal mass.

Authors:  R A Stahl; S Kudelka; M Paravicini; P Schollmeyer
Journal:  Nephron       Date:  1986       Impact factor: 2.847

8.  Prostaglandin synthesis inhibition during volume expansion: collecting duct function.

Authors:  D R Wilson; U Honrath; H Sonnenberg
Journal:  Kidney Int       Date:  1982-07       Impact factor: 10.612

9.  Inhibition by anticoagulant drugs of the progressive hypertension and uremia associated with renal infarction in rats.

Authors:  M L Purkerson; J H Joist; J M Greenberg; D Kay; P E Hoffsten; S Klahr
Journal:  Thromb Res       Date:  1982-05-15       Impact factor: 3.944

10.  Immune complex acute necrotizing glomerulonephritis with progression to diffuse glomerulosclerosis. A murine model.

Authors:  S S Iskandar; D R Gifford; S N Emancipator
Journal:  Lab Invest       Date:  1988-12       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.